Delivery Order SPE2DB20D1100-SPE2DB24FD5E1
Award Date
8/28/24
Potential Completion Date
8/29/24
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90-count packages. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This federal contract award is for the delivery of Valsartan-HCTZ 320-12.5 mg tablets in 90-count bottles to the Defense Logistics Agency (DLA). The $24,044.29 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award has an ultimate completion date of January 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $2,051.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90-count packages, with an ultimate completion date of April 17, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a $6,894.05 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,062,501 units of Valsartan-HCTZ 320-12.5 mg tablets. The contract has an ultimate completion date of January 29, 2025. This contract is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of Valsartan-HCTZ 320-12.5 mg tablets to the Defense Logistics Agency (DLA), a major defense agency under the Department of Defense. The $1,731.54 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a large pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
The federal contract award is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets, with a ceiling value of $9,807.11 and a completion date of July 24, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is registered in the System for Award Management (SAM.gov). The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that supports the U.S. military's medical needs. The contract is a...
The federal contract award is for the delivery of Valsartan-HCTZ 320-25 mg tablets to support the medical supply chain needs of the Defense Logistics Agency (DLA) Troop Support Medical. The $44,649.27 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 25, 2024 and was awarded on January 24, 2024. The award is not designated as a set-aside....
This federal contract award is for the delivery of Valsartan-HCTZ 160-25 mg tablets, a cardiovascular medication, to the Defense Logistics Agency (DLA). The $1,983.37 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) with the DLA. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award is for the delivery of Valsartan-HCTZ 160-25 mg tablets in 90-count packages. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $29,795.15 and is a firm fixed-price delivery order with a completion date of February 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,638.30 firm fixed-price delivery order is for the supply of Valsartan-HCTZ 320-25 mg tablets. The contract has an ultimate completion date of June 23, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...